Rank | Gene Set | Z-score |
---|---|---|
1 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.81389485 |
2 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.81389485 |
3 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.46094575 |
4 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.44419435 |
5 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.68760948 |
6 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.35651346 |
7 | ribosomal small subunit assembly (GO:0000028) | 4.34369659 |
8 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.33604574 |
9 | positive regulation of B cell differentiation (GO:0045579) | 4.22901719 |
10 | regulation of gamma-delta T cell activation (GO:0046643) | 4.04654992 |
11 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.01217042 |
12 | B cell receptor signaling pathway (GO:0050853) | 3.85885854 |
13 | regulation of B cell differentiation (GO:0045577) | 3.85679053 |
14 | negative T cell selection (GO:0043383) | 3.72403870 |
15 | negative thymic T cell selection (GO:0045060) | 3.66310629 |
16 | positive regulation by symbiont of host defense response (GO:0052509) | 3.66204562 |
17 | modulation by symbiont of host defense response (GO:0052031) | 3.66204562 |
18 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.66204562 |
19 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.66204562 |
20 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.66204562 |
21 | modulation by symbiont of host immune response (GO:0052553) | 3.66204562 |
22 | response to peptidoglycan (GO:0032494) | 3.63744764 |
23 | positive thymic T cell selection (GO:0045059) | 3.57785678 |
24 | negative regulation of T cell mediated immunity (GO:0002710) | 3.54900197 |
25 | negative regulation of phagocytosis (GO:0050765) | 3.54681519 |
26 | definitive hemopoiesis (GO:0060216) | 3.52544996 |
27 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.45870533 |
28 | detection of other organism (GO:0098543) | 3.41709870 |
29 | interferon-gamma production (GO:0032609) | 3.36750416 |
30 | negative regulation of interleukin-12 production (GO:0032695) | 3.31581895 |
31 | viral transcription (GO:0019083) | 3.29548581 |
32 | mast cell activation (GO:0045576) | 3.28228867 |
33 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.27470243 |
34 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.25433204 |
35 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.25089387 |
36 | T cell migration (GO:0072678) | 3.23086852 |
37 | detection of bacterium (GO:0016045) | 3.23010556 |
38 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.21961142 |
39 | thymic T cell selection (GO:0045061) | 3.20703801 |
40 | leukocyte aggregation (GO:0070486) | 3.20042143 |
41 | T cell homeostasis (GO:0043029) | 3.17723267 |
42 | hepatocyte apoptotic process (GO:0097284) | 3.17373167 |
43 | regulation of regulatory T cell differentiation (GO:0045589) | 3.17199752 |
44 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.16990600 |
45 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.16990600 |
46 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.16704355 |
47 | response to interleukin-15 (GO:0070672) | 3.16002894 |
48 | macrophage activation involved in immune response (GO:0002281) | 3.14969582 |
49 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.12165858 |
50 | translational termination (GO:0006415) | 3.11203577 |
51 | response to type I interferon (GO:0034340) | 3.09652030 |
52 | granulocyte activation (GO:0036230) | 3.08887422 |
53 | myeloid cell activation involved in immune response (GO:0002275) | 3.06929684 |
54 | T cell selection (GO:0045058) | 3.06413360 |
55 | megakaryocyte development (GO:0035855) | 3.05517674 |
56 | cellular response to type I interferon (GO:0071357) | 3.03904431 |
57 | type I interferon signaling pathway (GO:0060337) | 3.03904431 |
58 | immunoglobulin mediated immune response (GO:0016064) | 3.00376818 |
59 | neutrophil activation involved in immune response (GO:0002283) | 3.00343686 |
60 | response to protozoan (GO:0001562) | 3.00006328 |
61 | myeloid dendritic cell activation (GO:0001773) | 2.99702595 |
62 | * regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.98225620 |
63 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.97157127 |
64 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.96987349 |
65 | germinal center formation (GO:0002467) | 2.95477267 |
66 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.95360987 |
67 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.94486322 |
68 | tolerance induction (GO:0002507) | 2.92975693 |
69 | NIK/NF-kappaB signaling (GO:0038061) | 2.92045457 |
70 | positive T cell selection (GO:0043368) | 2.90287913 |
71 | detection of external biotic stimulus (GO:0098581) | 2.88342768 |
72 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.88101394 |
73 | lymphocyte homeostasis (GO:0002260) | 2.88092275 |
74 | cellular response to zinc ion (GO:0071294) | 2.82872641 |
75 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.82322300 |
76 | cellular response to interleukin-15 (GO:0071350) | 2.81720942 |
77 | response to host immune response (GO:0052572) | 2.81697839 |
78 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.81697839 |
79 | negative regulation of B cell proliferation (GO:0030889) | 2.81610686 |
80 | * regulation of T cell receptor signaling pathway (GO:0050856) | 2.79928602 |
81 | defense response to protozoan (GO:0042832) | 2.79781385 |
82 | detection of molecule of bacterial origin (GO:0032490) | 2.79395393 |
83 | microglial cell activation (GO:0001774) | 2.78862866 |
84 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.78830844 |
85 | leukocyte degranulation (GO:0043299) | 2.78205251 |
86 | regulation of tolerance induction (GO:0002643) | 2.78044646 |
87 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.74926489 |
88 | angiogenesis involved in wound healing (GO:0060055) | 2.74563439 |
89 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.74416113 |
90 | cotranslational protein targeting to membrane (GO:0006613) | 2.74272686 |
91 | protein targeting to ER (GO:0045047) | 2.74153462 |
92 | ribosomal small subunit biogenesis (GO:0042274) | 2.73872288 |
93 | regulation of mast cell degranulation (GO:0043304) | 2.73295636 |
94 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.72816264 |
95 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.72412247 |
96 | negative regulation of cell killing (GO:0031342) | 2.72412247 |
97 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.72288881 |
98 | T cell costimulation (GO:0031295) | 2.72285637 |
99 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.72159839 |
100 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.72159839 |
101 | positive regulation of mast cell activation (GO:0033005) | 2.72144166 |
102 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.71893194 |
103 | cellular extravasation (GO:0045123) | 2.71833016 |
104 | positive regulation of interleukin-2 production (GO:0032743) | 2.71808394 |
105 | positive regulation of interferon-alpha production (GO:0032727) | 2.71275005 |
106 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 2.70920065 |
107 | lymphocyte costimulation (GO:0031294) | 2.69511012 |
108 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.69317008 |
109 | neutrophil activation (GO:0042119) | 2.68252708 |
110 | leukocyte homeostasis (GO:0001776) | 2.67905275 |
111 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 2.67249015 |
112 | regulation of granulocyte differentiation (GO:0030852) | 2.67061409 |
113 | T cell receptor signaling pathway (GO:0050852) | 2.66764935 |
114 | positive regulation of tolerance induction (GO:0002645) | 2.65429666 |
115 | regulation of alpha-beta T cell activation (GO:0046634) | 2.65222671 |
116 | positive regulation of isotype switching (GO:0045830) | 2.64430572 |
117 | mature B cell differentiation (GO:0002335) | 2.64325456 |
118 | positive regulation of macrophage differentiation (GO:0045651) | 2.63465158 |
119 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.63058445 |
120 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 2.60585186 |
121 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.58733660 |
122 | response to muramyl dipeptide (GO:0032495) | 2.58657813 |
123 | mast cell activation involved in immune response (GO:0002279) | 2.58533241 |
124 | mast cell degranulation (GO:0043303) | 2.58533241 |
125 | positive regulation of granulocyte differentiation (GO:0030854) | 2.58494199 |
126 | regulation of B cell apoptotic process (GO:0002902) | 2.58236638 |
127 | regulation of T cell tolerance induction (GO:0002664) | 2.58127357 |
128 | translational elongation (GO:0006414) | 2.57869715 |
129 | natural killer cell activation (GO:0030101) | 2.57190304 |
130 | B cell homeostasis (GO:0001782) | 2.56704313 |
131 | protein localization to endoplasmic reticulum (GO:0070972) | 2.56084209 |
132 | B cell mediated immunity (GO:0019724) | 2.54111174 |
133 | regulation of response to interferon-gamma (GO:0060330) | 2.54006415 |
134 | mature B cell differentiation involved in immune response (GO:0002313) | 2.53488321 |
135 | regulation of necroptotic process (GO:0060544) | 2.51420102 |
136 | positive regulation of B cell activation (GO:0050871) | 2.51201853 |
137 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.50733836 |
138 | lymph node development (GO:0048535) | 2.49330902 |
139 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.48864671 |
140 | regulation of B cell proliferation (GO:0030888) | 2.46637403 |
141 | positive regulation of antigen processing and presentation (GO:0002579) | 2.45778019 |
142 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.45643294 |
143 | myeloid dendritic cell differentiation (GO:0043011) | 2.45238228 |
144 | regulation of B cell activation (GO:0050864) | 2.44646747 |
145 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 2.43501544 |
Rank | Gene Set | Z-score |
---|---|---|
1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.52470890 |
2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.71171080 |
3 | * FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.58285912 |
4 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.84849115 |
5 | * IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.66644352 |
6 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.27613778 |
7 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.07180278 |
8 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.05590093 |
9 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.05262255 |
10 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.94474225 |
11 | MYC_22102868_ChIP-Seq_BL_Human | 2.72492199 |
12 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.65863025 |
13 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.63383390 |
14 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.58045809 |
15 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.52743012 |
16 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.50591436 |
17 | MYB_26560356_Chip-Seq_TH2_Human | 2.50560244 |
18 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.39096170 |
19 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.36687908 |
20 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.36452791 |
21 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.36299908 |
22 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.35978719 |
23 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.30123948 |
24 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.28412498 |
25 | * MAF_26560356_Chip-Seq_TH1_Human | 2.21591481 |
26 | MYB_26560356_Chip-Seq_TH1_Human | 2.20521444 |
27 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.18972911 |
28 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.13698588 |
29 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.11058585 |
30 | GATA1_22025678_ChIP-Seq_K562_Human | 2.05950879 |
31 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.04271450 |
32 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.99910346 |
33 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.95131812 |
34 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.94633126 |
35 | UTX_26944678_Chip-Seq_JUKART_Human | 1.93703206 |
36 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.89700551 |
37 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.88616263 |
38 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.85612963 |
39 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.85211421 |
40 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.82483424 |
41 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.80180816 |
42 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.69227170 |
43 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.69188364 |
44 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.66995902 |
45 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.65021618 |
46 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.60546679 |
47 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.55676730 |
48 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.54152875 |
49 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.53806686 |
50 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.52362658 |
51 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.51177832 |
52 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.50699408 |
53 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.50178456 |
54 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.49956473 |
55 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.48565658 |
56 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.48473898 |
57 | GATA1_19941826_ChIP-Seq_K562_Human | 1.44494411 |
58 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.43028450 |
59 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.41842698 |
60 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.40295797 |
61 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.38087813 |
62 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.36552876 |
63 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.35560633 |
64 | MAF_26560356_Chip-Seq_TH2_Human | 1.34360641 |
65 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.33305398 |
66 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.31624764 |
67 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.31028647 |
68 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.30983977 |
69 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.27988537 |
70 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.27257701 |
71 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.26410108 |
72 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.26075547 |
73 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.24361864 |
74 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.24116242 |
75 | GATA2_19941826_ChIP-Seq_K562_Human | 1.23848312 |
76 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.23543232 |
77 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.21805653 |
78 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.20749695 |
79 | * FOXP3_21729870_ChIP-Seq_TREG_Human | 1.14991460 |
80 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.14235472 |
81 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.11721664 |
82 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.08906389 |
83 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.03955923 |
84 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.03678096 |
85 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.02647466 |
86 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.01219671 |
87 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.00362322 |
88 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.98914010 |
89 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.98832520 |
90 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.98324343 |
91 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.98034922 |
92 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.95586211 |
93 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.94694365 |
94 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.94586605 |
95 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.93049047 |
96 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.88624210 |
97 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.87801217 |
98 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.86233931 |
99 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.84684863 |
100 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.84393072 |
101 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.83602666 |
102 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.82805779 |
103 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 0.81065850 |
104 | * GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.79422724 |
105 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.78624733 |
106 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.77861828 |
107 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.77729962 |
108 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 0.77450531 |
109 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.77421833 |
110 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.77264642 |
111 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.76899126 |
112 | XRN2_22483619_ChIP-Seq_HELA_Human | 0.76341066 |
113 | GATA3_26560356_Chip-Seq_TH1_Human | 0.75551070 |
114 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.75080383 |
115 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.75067950 |
116 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.74619860 |
117 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.72031200 |
118 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.71285713 |
119 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.70752808 |
120 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.69486763 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0001835_abnormal_antigen_presentation | 3.77954019 |
2 | MP0003763_abnormal_thymus_physiology | 3.18281231 |
3 | MP0005671_abnormal_response_to | 3.15817643 |
4 | MP0001800_abnormal_humoral_immune | 2.95302263 |
5 | MP0002396_abnormal_hematopoietic_system | 2.94101186 |
6 | MP0000685_abnormal_immune_system | 2.85610097 |
7 | MP0002166_altered_tumor_susceptibility | 2.74222775 |
8 | MP0005387_immune_system_phenotype | 2.72812508 |
9 | MP0001790_abnormal_immune_system | 2.72812508 |
10 | * MP0002452_abnormal_antigen_presenting | 2.58544676 |
11 | MP0009785_altered_susceptibility_to | 2.55587543 |
12 | * MP0005000_abnormal_immune_tolerance | 2.54784919 |
13 | * MP0002420_abnormal_adaptive_immunity | 2.48678282 |
14 | * MP0002723_abnormal_immune_serum | 2.48163238 |
15 | * MP0001819_abnormal_immune_cell | 2.45485834 |
16 | * MP0002398_abnormal_bone_marrow | 2.41038520 |
17 | MP0003436_decreased_susceptibility_to | 2.40865190 |
18 | MP0005025_abnormal_response_to | 2.37354516 |
19 | MP0002148_abnormal_hypersensitivity_rea | 2.27254492 |
20 | MP0002006_tumorigenesis | 2.15674483 |
21 | MP0005464_abnormal_platelet_physiology | 2.14263949 |
22 | MP0002419_abnormal_innate_immunity | 2.13918411 |
23 | * MP0000716_abnormal_immune_system | 2.13047958 |
24 | MP0003300_gastrointestinal_ulcer | 2.11477775 |
25 | MP0001873_stomach_inflammation | 2.07499058 |
26 | MP0003724_increased_susceptibility_to | 2.06098431 |
27 | MP0010155_abnormal_intestine_physiology | 2.05756045 |
28 | MP0004808_abnormal_hematopoietic_stem | 2.04927228 |
29 | * MP0000689_abnormal_spleen_morphology | 1.98361524 |
30 | MP0002722_abnormal_immune_system | 1.96685522 |
31 | MP0002405_respiratory_system_inflammati | 1.96489779 |
32 | MP0001853_heart_inflammation | 1.94223890 |
33 | MP0003303_peritoneal_inflammation | 1.93720657 |
34 | MP0009333_abnormal_splenocyte_physiolog | 1.86315306 |
35 | MP0005397_hematopoietic_system_phenotyp | 1.84817786 |
36 | MP0001545_abnormal_hematopoietic_system | 1.84817786 |
37 | MP0000465_gastrointestinal_hemorrhage | 1.84068643 |
38 | MP0004947_skin_inflammation | 1.83648443 |
39 | * MP0002429_abnormal_blood_cell | 1.83153437 |
40 | MP0000703_abnormal_thymus_morphology | 1.80578705 |
41 | MP0001845_abnormal_inflammatory_respons | 1.64247134 |
42 | MP0003866_abnormal_defecation | 1.61743257 |
43 | MP0006054_spinal_hemorrhage | 1.60127149 |
44 | MP0005174_abnormal_tail_pigmentation | 1.58264806 |
45 | MP0000490_abnormal_crypts_of | 1.56888140 |
46 | MP0006082_CNS_inflammation | 1.48470827 |
47 | MP0009278_abnormal_bone_marrow | 1.43459567 |
48 | MP0008057_abnormal_DNA_replication | 1.41472576 |
49 | MP0003172_abnormal_lysosome_physiology | 1.37708092 |
50 | MP0010352_gastrointestinal_tract_polyps | 1.35709161 |
51 | MP0002933_joint_inflammation | 1.35214915 |
52 | MP0003656_abnormal_erythrocyte_physiolo | 1.34814080 |
53 | MP0005310_abnormal_salivary_gland | 1.33016007 |
54 | MP0003693_abnormal_embryo_hatching | 1.32705229 |
55 | MP0000858_altered_metastatic_potential | 1.29993813 |
56 | MP0002009_preneoplasia | 1.24000554 |
57 | MP0008007_abnormal_cellular_replicative | 1.20714218 |
58 | MP0010094_abnormal_chromosome_stability | 1.18155971 |
59 | MP0005075_abnormal_melanosome_morpholog | 1.16853250 |
60 | MP0008469_abnormal_protein_level | 1.16171495 |
61 | MP0002019_abnormal_tumor_incidence | 1.14778721 |
62 | MP0005451_abnormal_body_composition | 1.14690535 |
63 | MP0001533_abnormal_skeleton_physiology | 1.13396436 |
64 | MP0002095_abnormal_skin_pigmentation | 1.11701388 |
65 | MP0008004_abnormal_stomach_pH | 1.10221545 |
66 | MP0008260_abnormal_autophagy | 1.02100725 |
67 | MP0002877_abnormal_melanocyte_morpholog | 1.01833344 |
68 | MP0003077_abnormal_cell_cycle | 1.01751298 |
69 | MP0003448_altered_tumor_morphology | 1.00362627 |
70 | MP0001851_eye_inflammation | 0.98046774 |
71 | MP0002132_abnormal_respiratory_system | 0.95763228 |
72 | MP0005166_decreased_susceptibility_to | 0.93038536 |
73 | MP0010307_abnormal_tumor_latency | 0.88864478 |
74 | MP0004883_abnormal_blood_vessel | 0.88068797 |
75 | MP0003191_abnormal_cellular_cholesterol | 0.84923137 |
76 | MP0003045_fibrosis | 0.83276804 |
77 | MP0003183_abnormal_peptide_metabolism | 0.82337870 |
78 | MP0002138_abnormal_hepatobiliary_system | 0.81046691 |
79 | MP0004264_abnormal_extraembryonic_tissu | 0.80592216 |
80 | MP0003943_abnormal_hepatobiliary_system | 0.80312700 |
81 | MP0004381_abnormal_hair_follicle | 0.79606933 |
82 | MP0000015_abnormal_ear_pigmentation | 0.78983151 |
83 | MP0009764_decreased_sensitivity_to | 0.78965258 |
84 | MP0005023_abnormal_wound_healing | 0.78606343 |
85 | MP0003453_abnormal_keratinocyte_physiol | 0.77641450 |
86 | MP0003075_altered_response_to | 0.77090562 |
87 | MP0004957_abnormal_blastocyst_morpholog | 0.76695204 |
88 | MP0000604_amyloidosis | 0.76503087 |
89 | MP0003828_pulmonary_edema | 0.76470404 |
90 | MP0004510_myositis | 0.76386061 |
91 | MP0005164_abnormal_response_to | 0.75084927 |
92 | MP0002928_abnormal_bile_duct | 0.72692709 |
93 | MP0010234_abnormal_vibrissa_follicle | 0.72625978 |
94 | MP0003566_abnormal_cell_adhesion | 0.72401530 |
95 | MP0005076_abnormal_cell_differentiation | 0.72388091 |
96 | MP0005058_abnormal_lysosome_morphology | 0.72020227 |
97 | MP0000343_altered_response_to | 0.71838466 |
98 | MP0009765_abnormal_xenobiotic_induced | 0.71477149 |
99 | MP0009763_increased_sensitivity_to | 0.70168795 |
100 | MP0001216_abnormal_epidermal_layer | 0.69008164 |
101 | MP0002998_abnormal_bone_remodeling | 0.68908135 |
102 | MP0000569_abnormal_digit_pigmentation | 0.67973225 |
103 | MP0001663_abnormal_digestive_system | 0.67425754 |
104 | MP0005390_skeleton_phenotype | 0.65526028 |
105 | MP0001191_abnormal_skin_condition | 0.65435040 |
106 | MP0000477_abnormal_intestine_morphology | 0.64859433 |
107 | MP0000249_abnormal_blood_vessel | 0.64859245 |
108 | MP0003252_abnormal_bile_duct | 0.64169029 |
109 | MP0000313_abnormal_cell_death | 0.63663344 |
110 | MP0008058_abnormal_DNA_repair | 0.63383604 |
111 | MP0002136_abnormal_kidney_physiology | 0.63008736 |
112 | MP0003111_abnormal_nucleus_morphology | 0.62730879 |
113 | MP0002254_reproductive_system_inflammat | 0.62502406 |
114 | MP0009931_abnormal_skin_appearance | 0.62406972 |
115 | MP0002060_abnormal_skin_morphology | 0.61823911 |
116 | MP0009840_abnormal_foam_cell | 0.61348303 |
117 | MP0003795_abnormal_bone_structure | 0.60708997 |
118 | MP0003091_abnormal_cell_migration | 0.59236509 |
119 | MP0000609_abnormal_liver_physiology | 0.57361266 |
120 | MP0001765_abnormal_ion_homeostasis | 0.51728097 |
121 | MP0005381_digestive/alimentary_phenotyp | 0.49870499 |
122 | MP0004484_altered_response_of | 0.48880641 |
123 | MP0009115_abnormal_fat_cell | 0.48672602 |
Rank | Gene Set | Z-score |
---|---|---|
1 | IgM deficiency (HP:0002850) | 4.58038840 |
2 | Chronic otitis media (HP:0000389) | 4.32796423 |
3 | Recurrent viral infections (HP:0004429) | 4.27811226 |
4 | Recurrent bronchitis (HP:0002837) | 4.25664184 |
5 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.14636579 |
6 | Agammaglobulinemia (HP:0004432) | 3.98489266 |
7 | Recurrent fungal infections (HP:0002841) | 3.91276478 |
8 | T lymphocytopenia (HP:0005403) | 3.87521567 |
9 | Thrombocytosis (HP:0001894) | 3.86859645 |
10 | Myositis (HP:0100614) | 3.86385255 |
11 | Abnormality of T cell number (HP:0011839) | 3.83344587 |
12 | Recurrent abscess formation (HP:0002722) | 3.79722898 |
13 | Panhypogammaglobulinemia (HP:0003139) | 3.73984420 |
14 | Abnormality of B cell number (HP:0010975) | 3.72778969 |
15 | B lymphocytopenia (HP:0010976) | 3.72778969 |
16 | Eczematoid dermatitis (HP:0000976) | 3.66016966 |
17 | Cellulitis (HP:0100658) | 3.63207559 |
18 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.58321589 |
19 | Abnormality of T cells (HP:0002843) | 3.57904846 |
20 | Meningitis (HP:0001287) | 3.54184040 |
21 | Thyroiditis (HP:0100646) | 3.52422504 |
22 | Recurrent bacterial skin infections (HP:0005406) | 3.51713046 |
23 | Petechiae (HP:0000967) | 3.45288141 |
24 | Abnormality of T cell physiology (HP:0011840) | 3.31411617 |
25 | Gastrointestinal infarctions (HP:0005244) | 3.20308202 |
26 | Abnormality of the fingertips (HP:0001211) | 3.19403293 |
27 | IgG deficiency (HP:0004315) | 3.18427479 |
28 | Lymphopenia (HP:0001888) | 3.12891958 |
29 | Severe combined immunodeficiency (HP:0004430) | 3.12800126 |
30 | Vasculitis (HP:0002633) | 3.10682859 |
31 | Inflammation of the large intestine (HP:0002037) | 3.09806994 |
32 | Gastrointestinal inflammation (HP:0004386) | 3.08381400 |
33 | Prolonged bleeding time (HP:0003010) | 3.08191650 |
34 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 3.04753543 |
35 | Spontaneous hematomas (HP:0007420) | 3.02776312 |
36 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.00090731 |
37 | Recurrent cutaneous fungal infections (HP:0011370) | 3.00090731 |
38 | Nasal polyposis (HP:0100582) | 2.97302921 |
39 | Eosinophilia (HP:0001880) | 2.96361883 |
40 | Combined immunodeficiency (HP:0005387) | 2.87157603 |
41 | Pustule (HP:0200039) | 2.86641294 |
42 | Gastrointestinal stroma tumor (HP:0100723) | 2.81799584 |
43 | Granulocytopenia (HP:0001913) | 2.81088105 |
44 | Recurrent skin infections (HP:0001581) | 2.80494269 |
45 | Orchitis (HP:0100796) | 2.77296745 |
46 | Retrobulbar optic neuritis (HP:0100654) | 2.75837743 |
47 | Optic neuritis (HP:0100653) | 2.75837743 |
48 | Abnormality of eosinophils (HP:0001879) | 2.73985687 |
49 | Autoimmune thrombocytopenia (HP:0001973) | 2.71931547 |
50 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.71637959 |
51 | Reticulocytopenia (HP:0001896) | 2.71571109 |
52 | Hypoplasia of the thymus (HP:0000778) | 2.71518706 |
53 | Abnormality of the nasal mucosa (HP:0000433) | 2.71125550 |
54 | Increased IgM level (HP:0003496) | 2.69773656 |
55 | Leukocytosis (HP:0001974) | 2.67352556 |
56 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.67072381 |
57 | Colitis (HP:0002583) | 2.67029857 |
58 | Papilloma (HP:0012740) | 2.64037483 |
59 | Verrucae (HP:0200043) | 2.64037483 |
60 | Epistaxis (HP:0000421) | 2.63825575 |
61 | Abnormal number of erythroid precursors (HP:0012131) | 2.62734606 |
62 | Chronic diarrhea (HP:0002028) | 2.62451030 |
63 | IgA deficiency (HP:0002720) | 2.60455597 |
64 | Mediastinal lymphadenopathy (HP:0100721) | 2.60092508 |
65 | Autoimmune hemolytic anemia (HP:0001890) | 2.58735925 |
66 | Abnormality of the prostate (HP:0008775) | 2.57409425 |
67 | Interstitial pulmonary disease (HP:0006530) | 2.56608725 |
68 | Impaired platelet aggregation (HP:0003540) | 2.56216324 |
69 | Abnormal platelet function (HP:0011869) | 2.56216324 |
70 | Lymphoma (HP:0002665) | 2.55501108 |
71 | Increased IgE level (HP:0003212) | 2.53031682 |
72 | Urticaria (HP:0001025) | 2.50432833 |
73 | Encephalitis (HP:0002383) | 2.49086847 |
74 | Osteomyelitis (HP:0002754) | 2.49029815 |
75 | Obstructive lung disease (HP:0006536) | 2.46782692 |
76 | Chronic obstructive pulmonary disease (HP:0006510) | 2.46782692 |
77 | Gingivitis (HP:0000230) | 2.46753464 |
78 | Recurrent sinusitis (HP:0011108) | 2.46538311 |
79 | Pulmonary embolism (HP:0002204) | 2.44382578 |
80 | Acute myeloid leukemia (HP:0004808) | 2.42982133 |
81 | Bronchitis (HP:0012387) | 2.41382491 |
82 | Chronic sinusitis (HP:0011109) | 2.40522916 |
83 | Abnormal platelet volume (HP:0011876) | 2.40249695 |
84 | Gangrene (HP:0100758) | 2.39964755 |
85 | Gingival bleeding (HP:0000225) | 2.37266640 |
86 | Periodontitis (HP:0000704) | 2.36210354 |
87 | Arterial thrombosis (HP:0004420) | 2.31839187 |
88 | Pulmonary infiltrates (HP:0002113) | 2.31540810 |
89 | Viral hepatitis (HP:0006562) | 2.29356725 |
90 | Joint swelling (HP:0001386) | 2.28580681 |
91 | Sepsis (HP:0100806) | 2.24565835 |
92 | Fatigue (HP:0012378) | 2.24290381 |
93 | Keratoconjunctivitis sicca (HP:0001097) | 2.19898802 |
94 | Hemoptysis (HP:0002105) | 2.19819747 |
95 | Abnormality of macrophages (HP:0004311) | 2.19693906 |
96 | Stomatitis (HP:0010280) | 2.18546669 |
97 | Aplastic anemia (HP:0001915) | 2.17333044 |
98 | Amaurosis fugax (HP:0100576) | 2.15958100 |
99 | Skin ulcer (HP:0200042) | 2.15884854 |
100 | Acute lymphatic leukemia (HP:0006721) | 2.15141088 |
101 | Recurrent pneumonia (HP:0006532) | 2.14899750 |
102 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.14394963 |
103 | Increased mean platelet volume (HP:0011877) | 2.11466984 |
104 | Polyneuropathy (HP:0001271) | 2.09937312 |
105 | Menorrhagia (HP:0000132) | 2.08960358 |
106 | Emphysema (HP:0002097) | 2.06779165 |
107 | Hypergammaglobulinemia (HP:0010702) | 2.05465062 |
108 | Chest pain (HP:0100749) | 2.05304051 |
109 | Recurrent lower respiratory tract infections (HP:0002783) | 2.03565861 |
110 | Abnormality of the pleura (HP:0002103) | 2.03089445 |
111 | Acute hepatic failure (HP:0006554) | 2.02892397 |
112 | Keratoconjunctivitis (HP:0001096) | 2.02635712 |
113 | Prostate neoplasm (HP:0100787) | 2.00455528 |
114 | Purpura (HP:0000979) | 1.95866320 |
115 | Hypoproteinemia (HP:0003075) | 1.95444932 |
116 | Hypochromic anemia (HP:0001931) | 1.95357785 |
117 | Anorexia (HP:0002039) | 1.95122460 |
118 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.94996320 |
119 | Neutropenia (HP:0001875) | 1.94637321 |
120 | Poikiloderma (HP:0001029) | 1.94504960 |
121 | Skin rash (HP:0000988) | 1.93225949 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MAP4K1 | 4.34029414 |
2 | TXK | 3.05045466 |
3 | MAP3K14 | 2.36653250 |
4 | TYK2 | 2.33543812 |
5 | TEC | 2.30830735 |
6 | JAK3 | 2.29598846 |
7 | BTK | 2.28430791 |
8 | EEF2K | 2.27518899 |
9 | KIT | 2.24095362 |
10 | STK10 | 2.19916673 |
11 | MAP3K10 | 2.15741397 |
12 | PRPF4B | 2.14758920 |
13 | IRAK4 | 2.13284848 |
14 | BMPR2 | 2.11849687 |
15 | IKBKE | 2.06468135 |
16 | ZAP70 | 2.05514088 |
17 | ITK | 1.99056828 |
18 | TBK1 | 1.94125778 |
19 | MST4 | 1.75776575 |
20 | BLK | 1.72863325 |
21 | SYK | 1.67357061 |
22 | TAOK3 | 1.65914822 |
23 | CSF1R | 1.56164089 |
24 | IKBKB | 1.55597463 |
25 | TAOK2 | 1.55276467 |
26 | GRK6 | 1.53236050 |
27 | LRRK2 | 1.45123217 |
28 | TAOK1 | 1.42608584 |
29 | PIM1 | 1.41840566 |
30 | LCK | 1.40911306 |
31 | FGFR3 | 1.39717750 |
32 | FGFR4 | 1.38872836 |
33 | JAK1 | 1.38044716 |
34 | TGFBR2 | 1.35189342 |
35 | FLT3 | 1.32826090 |
36 | PIM2 | 1.31821264 |
37 | NLK | 1.31180113 |
38 | ERN1 | 1.28453539 |
39 | MAP2K3 | 1.27891374 |
40 | MKNK2 | 1.27268648 |
41 | RPS6KA4 | 1.27180021 |
42 | RPS6KB2 | 1.26935988 |
43 | IRAK1 | 1.26460331 |
44 | NME2 | 1.25697474 |
45 | MAP3K11 | 1.20561267 |
46 | MAP3K1 | 1.20156778 |
47 | IRAK3 | 1.18621121 |
48 | CSK | 1.18563119 |
49 | CLK1 | 1.14023677 |
50 | HCK | 1.14000519 |
51 | STK4 | 1.09927509 |
52 | LYN | 1.08822344 |
53 | CHUK | 1.07998340 |
54 | TGFBR1 | 1.07278614 |
55 | TRPM7 | 0.98965534 |
56 | EPHB1 | 0.97418405 |
57 | NUAK1 | 0.91980546 |
58 | FRK | 0.87772750 |
59 | TESK2 | 0.86426892 |
60 | HIPK2 | 0.84285315 |
61 | KDR | 0.81831276 |
62 | SCYL2 | 0.80887944 |
63 | IRAK2 | 0.79737251 |
64 | FES | 0.77966548 |
65 | FGR | 0.76592180 |
66 | NEK2 | 0.74702198 |
67 | CDK4 | 0.74312958 |
68 | CDK6 | 0.72414119 |
69 | STK16 | 0.72058754 |
70 | PASK | 0.71792277 |
71 | VRK1 | 0.71272415 |
72 | BRSK2 | 0.70916468 |
73 | MATK | 0.70627283 |
74 | PKN2 | 0.69923171 |
75 | PDK1 | 0.69793939 |
76 | ACVR1B | 0.66756585 |
77 | JAK2 | 0.66692902 |
78 | MAP3K13 | 0.66105538 |
79 | PRKCQ | 0.65877649 |
80 | TNK2 | 0.64926029 |
81 | MAP3K3 | 0.63063871 |
82 | RIPK4 | 0.62133737 |
83 | CDK9 | 0.60184783 |
84 | NEK9 | 0.60010632 |
85 | MAP3K5 | 0.58727005 |
86 | MAPK4 | 0.57933410 |
87 | DYRK3 | 0.57840973 |
88 | MARK3 | 0.57090494 |
89 | MKNK1 | 0.56421946 |
90 | MAP3K2 | 0.56257576 |
91 | CDK12 | 0.56136507 |
92 | MAPK7 | 0.54289739 |
93 | EPHA3 | 0.53255917 |
94 | PRKG2 | 0.53133685 |
95 | PIK3CA | 0.53016262 |
96 | MAPK11 | 0.52834473 |
97 | ATR | 0.52549392 |
98 | MAP2K2 | 0.52467092 |
99 | RPS6KA5 | 0.52425754 |
100 | CAMKK2 | 0.52172776 |
101 | MAPK12 | 0.51839113 |
102 | PIK3CG | 0.51358761 |
103 | CDC7 | 0.50348961 |
104 | TLK1 | 0.48604389 |
105 | EIF2AK3 | 0.48013417 |
106 | MAPKAPK2 | 0.47865666 |
107 | MAP3K8 | 0.47786796 |
108 | RPS6KA6 | 0.47460153 |
109 | TRIB3 | 0.47172366 |
110 | MAPKAPK3 | 0.46673210 |
111 | NEK6 | 0.43553133 |
112 | PDPK1 | 0.42844193 |
113 | PTK6 | 0.42191943 |
114 | AURKB | 0.40194907 |
115 | RET | 0.38482238 |
116 | MAPKAPK5 | 0.38118745 |
117 | EIF2AK1 | 0.36921011 |
118 | TSSK6 | 0.36218748 |
119 | RPS6KC1 | 0.36065489 |
120 | RPS6KL1 | 0.36065489 |
121 | STK24 | 0.35765339 |
122 | ABL1 | 0.35582544 |
123 | MAP3K7 | 0.34357062 |
124 | BRD4 | 0.34193244 |
125 | SIK3 | 0.33347976 |
126 | MAPK3 | 0.32352162 |
127 | FYN | 0.32144189 |
128 | YES1 | 0.31944967 |
129 | KSR2 | 0.31901922 |
130 | IGF1R | 0.26518478 |
131 | GRK7 | 0.25343696 |
132 | RAF1 | 0.24694843 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 4.06490351 |
2 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.54618129 |
3 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.53564638 |
4 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.45855654 |
5 | Leishmaniasis_Homo sapiens_hsa05140 | 2.37132415 |
6 | Measles_Homo sapiens_hsa05162 | 2.31183067 |
7 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.30682763 |
8 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.22492885 |
9 | Ribosome_Homo sapiens_hsa03010 | 2.21192919 |
10 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.18437723 |
11 | DNA replication_Homo sapiens_hsa03030 | 2.14636626 |
12 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.94330235 |
13 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.90253008 |
14 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.87500889 |
15 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.86320107 |
16 | Allograft rejection_Homo sapiens_hsa05330 | 1.84279112 |
17 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.81240737 |
18 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.78868620 |
19 | Mismatch repair_Homo sapiens_hsa03430 | 1.68330738 |
20 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.66078074 |
21 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.64771782 |
22 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.54256621 |
23 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.51447897 |
24 | Base excision repair_Homo sapiens_hsa03410 | 1.51029494 |
25 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.49516669 |
26 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.45928366 |
27 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.32583560 |
28 | Influenza A_Homo sapiens_hsa05164 | 1.31653027 |
29 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.28713130 |
30 | Apoptosis_Homo sapiens_hsa04210 | 1.27261476 |
31 | Legionellosis_Homo sapiens_hsa05134 | 1.26222855 |
32 | Hepatitis B_Homo sapiens_hsa05161 | 1.24607685 |
33 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.23763073 |
34 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.23361673 |
35 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.20732829 |
36 | Platelet activation_Homo sapiens_hsa04611 | 1.19239210 |
37 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.18084260 |
38 | Shigellosis_Homo sapiens_hsa05131 | 1.18082996 |
39 | Pertussis_Homo sapiens_hsa05133 | 1.16258802 |
40 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.15805510 |
41 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.15127655 |
42 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.14626280 |
43 | Homologous recombination_Homo sapiens_hsa03440 | 1.14309502 |
44 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.10877185 |
45 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.10581907 |
46 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.09739792 |
47 | Viral myocarditis_Homo sapiens_hsa05416 | 1.09126793 |
48 | Malaria_Homo sapiens_hsa05144 | 1.06788111 |
49 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.04334354 |
50 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.02342601 |
51 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.00822994 |
52 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.99793065 |
53 | Asthma_Homo sapiens_hsa05310 | 0.99679517 |
54 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.97427876 |
55 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.96636337 |
56 | Spliceosome_Homo sapiens_hsa03040 | 0.95820224 |
57 | Tuberculosis_Homo sapiens_hsa05152 | 0.95700871 |
58 | Other glycan degradation_Homo sapiens_hsa00511 | 0.95583738 |
59 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.92429419 |
60 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.89451366 |
61 | Hepatitis C_Homo sapiens_hsa05160 | 0.87135237 |
62 | HTLV-I infection_Homo sapiens_hsa05166 | 0.86734739 |
63 | Cell cycle_Homo sapiens_hsa04110 | 0.86209951 |
64 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.85093520 |
65 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.84773468 |
66 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.82335360 |
67 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.80565023 |
68 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.79419354 |
69 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.75849605 |
70 | Salmonella infection_Homo sapiens_hsa05132 | 0.75152078 |
71 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.73649924 |
72 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.72408040 |
73 | Protein export_Homo sapiens_hsa03060 | 0.71588966 |
74 | Phagosome_Homo sapiens_hsa04145 | 0.70120436 |
75 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.70015128 |
76 | RNA degradation_Homo sapiens_hsa03018 | 0.69354556 |
77 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.69205678 |
78 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.64725943 |
79 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.62545344 |
80 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.61331374 |
81 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.60957479 |
82 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.60147635 |
83 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.59574454 |
84 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.58854934 |
85 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.58464817 |
86 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.56913467 |
87 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.55341573 |
88 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.54802087 |
89 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.54287468 |
90 | Insulin resistance_Homo sapiens_hsa04931 | 0.53972794 |
91 | Amoebiasis_Homo sapiens_hsa05146 | 0.53259038 |
92 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.53184382 |
93 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.53062809 |
94 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.52532369 |
95 | Endometrial cancer_Homo sapiens_hsa05213 | 0.52472658 |
96 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.51702010 |
97 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.46143466 |
98 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.45806670 |
99 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.45245451 |
100 | Thyroid cancer_Homo sapiens_hsa05216 | 0.45014552 |
101 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.44656334 |
102 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.43251674 |
103 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.41437894 |
104 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.41399935 |
105 | Endocytosis_Homo sapiens_hsa04144 | 0.41175166 |
106 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.39810143 |
107 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.38904273 |
108 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.38193675 |
109 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.38043859 |
110 | Colorectal cancer_Homo sapiens_hsa05210 | 0.37694214 |
111 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.37375653 |
112 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.34582107 |
113 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.34456495 |
114 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.34392886 |
115 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.34034013 |
116 | Lysosome_Homo sapiens_hsa04142 | 0.33814526 |
117 | ABC transporters_Homo sapiens_hsa02010 | 0.33712944 |
118 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.33282439 |
119 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.32918110 |
120 | Prostate cancer_Homo sapiens_hsa05215 | 0.32483618 |
121 | RNA polymerase_Homo sapiens_hsa03020 | 0.31326611 |
122 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.29862688 |
123 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.29815672 |
124 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.29674932 |
125 | Pathways in cancer_Homo sapiens_hsa05200 | 0.29490699 |
126 | RNA transport_Homo sapiens_hsa03013 | 0.29274873 |
127 | Glioma_Homo sapiens_hsa05214 | 0.27544264 |
128 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.26714415 |
129 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.26580877 |
130 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.25664990 |
131 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.23955295 |